Euro-Pharmacies Nandrolone Phenylpropionate 10 ml vial (100 mg/ml)

Nandroloon fenüülpropionaat

Nandroloon fenüülpropionaat is a fast-acting injectable form of the anabolic steroid nandrolone. With properties similar to Deca-Durabolin, which uses the slower nandrolone decanoate, the key difference lies in release speed: nandroloon dekanoaat operates over a 3-week period, whereas phenylpropionate remains active for only about a week. Athletes often prefer Nandroloon fenüülpropionaat for its effective promotion of strength and lean muscle mass gains, minimizing estrogenic and androgenic side effects.

Struktuurilised omadused

The nandroloonfenüülpropionaat features a propionic phenyl ester linked to the 17-beta hydroxyl group, allowing for slower absorption and prolonged therapeutic effects. The ester conversion to active nandrolone results in notable effects 24 to 48 hours post-injection, tapering off within a week.

Kõrvaltoimed (östrogeensed)

Nandrolone conversion to estrogen is minimal, estimated at only 20% of testosterone’s propensity. While estrogenic symptoms like water retention and gynecomastia may arise at higher doses, they are rare with Nandroloon fenüülpropionaat. Anti-estrogens or aromatase inhibitors such as Arimidex may be used to mitigate potential side effects.

Kõrvaltoimed (androgeensed)

Although largely anabolic, androgenic side effects may occur at higher doses, leading to oily skin, acne, and body hair growth. Women risk virilizing symptoms like deepened voices and menstrual irregularities. The lower androgenic activity of nandrolone means side effects will be less pronounced compared to more androgenic steroids.

Kõrvaltoimed (hepatotoksilisus)

Free from c-17 alpha alkylation, Nandroloon fenüülpropionaat has no known hepatotoxic effects, making liver toxicity unlikely in healthy individuals.

Kõrvaltoimed (kardiovaskulaarsed)

The use of anabolic/androgenic steroids can negatively impact cholesterol levels, specifically reducing HDL and elevating LDL. Studies show a detrimental influence of nandrolone on HDL cholesterol, making cardiovascular care crucial for users.

Kõrvaltoimed (testosterooni supressioon)

All anabolic/androgenic steroids can suppress natural testosterone production. Research indicates substantial reductions in testosterone levels with nandrolone administration, often linked to its progestational activity. Recovery of testosterone levels typically occurs within 2 to 6 months post-therapy.

Administratsioon (mehed)

For desired anabolic effects, initial recommendations for men suggest a dosage of 25 to 50mg weekly for 12 weeks, with performance enhancement dosages ranging from 200 to 400mg weekly, divided into two applications.

Administration (Women)

Guidelines for women mirror male recommendations for general effects, with a common dosage of 50mg weekly for 4 to 6-week cycles. Caution is advised to minimize risks of virilization; immediate discontinuation is necessary if such effects occur.